Virological Changes of Chronic Hepatitis B Patients with Minimally Elevated Levels of Alanine Aminotransferase: A Meta-Analysis and Systematic Review

Figure 3

The outcomes of HBsAg seroconversion. (a) Pooled risk ratio for HBsAg seroconversion between the antiviral therapy group and control group. (b) Subgroup analysis stratified by therapeutic regimen with or without IFN. IFN, interferon; CI, confidence interval. The size of square represents the weight of each study, and the vertical dotted line represents the pooled rate.

(a)

(b)